- Sweden
- /
- Household Products
- /
- OM:ESSITY B
Essity (OM:ESSITY B): Exploring the Valuation Behind Recent Share Stability and Analyst Price Targets
Reviewed by Simply Wall St
Essity (OM:ESSITY B) shares have edged up slightly over the past month, adding a bit more than 0.1%. Investors watching the Swedish hygiene and health company can note this modest uptick as broader market dynamics and sector shifts continue to play out.
See our latest analysis for Essity.
The share price recently slipped lower year-to-date but has started to show some stability. Although the 1-year total shareholder return sits at -9.3%, those who held on for the past three or five years have still seen a respectable double-digit gain. With momentum wobbling yet not entirely lost, investors are watching to see if confidence returns or if recent pressure forces a further re-think on valuation.
If you're wondering what other names are worth a look right now, this could be a smart time to broaden your search and discover fast growing stocks with high insider ownership
With Essity shares showing signs of steadiness and a notable discount to analysts' price targets, investors may be considering whether the current weakness presents a genuine buying opportunity or if the market has already incorporated all future growth into the price.
Most Popular Narrative: 6.9% Undervalued
Essity’s fair value is pegged at SEK 281.08 by the most widely followed narrative, implying a moderate upside from the last close of SEK 261.8. This perspective invites a closer look at the underlying business factors that drive this valuation.
Essity is experiencing strong growth in Feminine Care and Incontinence Retail segments across multiple geographies, leveraging rising healthcare standards and expanding middle class in emerging markets, supporting expectations of international revenue expansion.
What financial trend is fueling this optimism? The answer hinges on steady global demand, strategic expansion, and ambitious profit projections that push this valuation higher than you might expect. Wonder what percentage growth and margin leap powers this fair value? The full narrative reveals all the quantitative details behind the analysts' consensus target.
Result: Fair Value of $281.08 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent soft demand in key segments or higher costs could quickly challenge optimism around Essity’s projected rebound and anticipated margin improvement.
Find out about the key risks to this Essity narrative.
Build Your Own Essity Narrative
If you see things differently or like to dig into the numbers yourself, you can craft your own view in just a few minutes. Do it your way
A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Essity.
Looking for More Smart Stock Picks?
Seize your edge by tapping into unique opportunities tailored for savvy investors. Stay ahead, act now, and don’t let these potential market movers slip by.
- Boost your returns by targeting leading innovators with strong recurring revenue and market expansion. Start your search with these 27 AI penny stocks.
- Maximize your portfolio’s upside by uncovering quality companies trading for less than their intrinsic value using these 894 undervalued stocks based on cash flows.
- Capture consistent income streams and lower risk while gaining exposure to high-yield opportunities with these 18 dividend stocks with yields > 3%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Essity might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About OM:ESSITY B
Essity
Develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
Community Narratives

